Kimberly-Clark earnings beat by $0.09, revenue topped estimates

Kimberly-Clark (KMB) reported Q3 EPS of $1.70, beating estimates by $0.09, with revenue of $4.13B, exceeding expectations. Shares closed at $108.79, down 0.81% over 3 months but up 7.96% year-over-year. The company had 12 negative EPS revisions in the last 90 days.

Original reporting
Published Nov 5, 2026, 11:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$KMB
Bullish
high confidence
Mentioned
$KMB
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$KMBBullishHigh
01

Why it matters

The earnings beat could prompt short‑term buying, but lack of guidance tempers expectations.

02

Market read

Earnings beat for a large‑cap consumer staple may influence sector sentiment and short‑term price action.

03

What to watch

No guidance provided; future performance remains uncertain.

Relevance 8/10Novelty 8/10Timing: after market close

Background

Kimberly-Clark is a leading consumer‑goods company; its quarterly earnings are closely watched for trends in discretionary spending.

Company-level read

Ticker impact

$KMBBullishHigh confidence
Context

Kimberly-Clark reported Q3 EPS of $1.70 beating estimates by $0.09 and revenue of $4.13B topping forecasts by $0.02B.

Expected impact

potential modest upside as market absorbs beat

Evidence & confidence

The beat is modest but above expectations for a large‑cap consumer staple, likely prompting short‑term buying pressure.

Market effects

May lift consumer staples sector as earnings beat signals resilience in demand for household products.

U.S. market may see slight gain in consumer staple indices.

Limited to U.S. investors; no broader global effect.

Counterpoint

The beat is modest; investors may already price in the result, limiting upside.

Key entities

  • Kimberly-Clark

    Consumer staples manufacturer reporting Q3 results.

Related articles

$KMBMedAI 8/10

Kimberly-Clark’s Dividend Is Up 392% Since 1999. Can Its $49 Billion Deal Put That at Risk?

Kimberly-Clark (KMB) has increased its dividend by 392% since 1999, with a current quarterly payout of $1.28. The company's $49 billion acquisition of Kenvue, funded partly by debt, may test its dividend streak. In 2025, free cash flow was $1.64 billion, slightly below the $1.66 billion paid in dividends. Management aims for reduced leverage and cost synergies to support earnings and the dividend.

$KMBMedAI 8/10

Kimberly-Clark backs 2026 outlook despite China disruptions

Kimberly-Clark reported Q3 2026 net sales of $4.13B, down 0.4% YoY, with adjusted EPS up 17.2% to $1.70. China disruptions and North American inventory movements impacted sales. The company reaffirmed its 2026 outlook, expecting mid-single-digit adjusted operating profit growth and high single-digit adjusted EPS growth.

$KMBMed

Kimberly-Clark Corp (KMB) (Q3 2026) Earnings Call Highlights: Kenvue Deal Closes

Kimberly-Clark (KMB) CEO Mike Hsu and CFO Nelson Urdaneta discussed Q3 2026 earnings, Kenvue integration, and 2027 outlook. Hsu highlighted Kenvue's 3% organic growth and progress in brand performance. Urdaneta cited cost-mitigating actions and easier Q4 comparisons. They addressed North America's share performance, diaper market dynamics, and synergy plans, including $1.9B in cost savings. KMB maintained fiscal 2026 guidance despite challenges.